Logo

New biomarker may guide best use of KRAS inhibitors in lung cancer

New biomarker may guide best use of KRAS inhibitors in lung cancer

Researchers from The University of Texas MD Anderson Cancer Center have identified a new biomarker, TTF-1, that was predictive of survival outcomes for patients with advanced KRAS G12C-mutated non-small cell lung cancer (NSCLC), following treatment with the KRAS targeted therapy sotorasib.

👉 Full Story

Cop’s “Black Fatigue” Gets Him in Trouble During Viral Arrest đŸ€Ż
Cop’s “Black Fatigue” Gets Him in Trouble During Viral Arrest đŸ€Ż
The Real Truth About Nothing's Budget Phone! *30-Days Review*
The Real Truth About Nothing's Budget Phone! *30-Days Review*